MXCT - MaxCyte, Inc.
About MaxCyte, Inc. (https://www.maxcyte.com)
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Maher Masoud | President, Chief Executive Officer & Executive Director | 1976 | $919,082 USD |
| Parmeet Ahuja | Chief Financial Officer | 1969 | $700,557 USD |
| Ana-Paula Martins Fernandes | Senior Vice President of Global Sales | – | – |
| Jack Horgan | Senior Vice President of Corporate Development | – | – |
| Jay Gelfman | Chief Operations Officer | – | – |
| Jill Mayer | Senior Vice President of Human Resources | – | – |
| Sidharth Kapileshwar | Chief Corporate Development Officer | – | – |